<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Irrational Markets's Comments</title>
    <description>Irrational Markets's Comments RSS Syndication from SeekingAlpha.com</description>
    <link>http://seekingalpha.com/user/444872/comments</link>
    <item>
      <title>The Latest On Amarin - How Will The Investment Pay Off?</title>
      <link>http://seekingalpha.com/article/1003301/comments?source=feed#comment-11628001</link>
      <guid isPermaLink="false">11628001</guid>
      <content>
        <![CDATA[Steve-  Great article.  Thanks for making some solid points.  <br/><br/>On the NCE, it's interesting that AMRN hasn't come out and said anything the last couple of days.  Last month, they issued a statement a few days before the Orange Book was updated...saying they did not believe Vascepa would be added to the OB due to a lack of communication from FDA.  The fact that they're not saying anything this time implies that the FDA has informed them about a decision.  If it was a negative decision, aren't they required to let their investors know as soon as the FDA tells them?  <br/><br/>Also, what are your thoughts on the pps for Friday if NCE gets approved or denied?  I'm thinking $15+ if they get NCE (they went over $14 last month based on some old article that implied they'd get NCE) and...gulp....$8 if they don't.  <br/><br/>Since you're Long on AMRN, how do you plan on dealing with the potentially binary event on Friday?  ]]>
      </content>
      <pubDate>Thu, 15 Nov 2012 05:18:20 -0500</pubDate>
      <description>
        <![CDATA[Steve-  Great article.  Thanks for making some solid points.  <br/><br/>On the NCE, it's interesting that AMRN hasn't come out and said anything the last couple of days.  Last month, they issued a statement a few days before the Orange Book was updated...saying they did not believe Vascepa would be added to the OB due to a lack of communication from FDA.  The fact that they're not saying anything this time implies that the FDA has informed them about a decision.  If it was a negative decision, aren't they required to let their investors know as soon as the FDA tells them?  <br/><br/>Also, what are your thoughts on the pps for Friday if NCE gets approved or denied?  I'm thinking $15+ if they get NCE (they went over $14 last month based on some old article that implied they'd get NCE) and...gulp....$8 if they don't.  <br/><br/>Since you're Long on AMRN, how do you plan on dealing with the potentially binary event on Friday?  ]]>
      </description>
    </item>
    <item>
      <title>Want to short so bad I can taste it...</title>
      <link>http://seekingalpha.com/instablog/19597-gary-tanashian/20947-want-to-short-so-bad-i-can-taste-it?source=feed#comment-622814</link>
      <guid isPermaLink="false">622814</guid>
      <content>
        <![CDATA[GS agrees it's time to short REIT stocks?<br/><br/><a rel='nofollow' target='_blank' href='http://tulpenwoede.tornflag.com/statemar.pdf'>tulpenwoede.tornflag.c...</a>]]>
      </content>
      <pubDate>Mon, 10 Aug 2009 01:56:46 -0400</pubDate>
      <description>
        <![CDATA[GS agrees it's time to short REIT stocks?<br/><br/><a rel='nofollow' target='_blank' href='http://tulpenwoede.tornflag.com/statemar.pdf'>tulpenwoede.tornflag.c...</a>]]>
      </description>
    </item>
  </channel>
</rss>
